Adhesive capsulitis of the shoulder, treatment with corticosteroid, corticosteroid with distension or treatment-as-usual; a randomised controlled trial in primary care

被引:37
|
作者
Sharma, Satya Pal [1 ]
Baerheim, Anders [1 ]
Moe-Nilssen, Rolf [2 ]
Kvale, Alice [2 ,3 ]
机构
[1] Univ Bergen, Dept Global Hlth & Primary Care, Sect Gen Practice, Res Grp, Kalfarveien 31, N-5018 Bergen, Norway
[2] Univ Bergen, Dept Global Publ Hlth & Primary Care, Physiotherapy Res Grp, Bergen, Norway
[3] Bergen Univ Coll, Dept Occupat Therapy Physiotherapy & Radiog, Bergen, Norway
关键词
Adhesive capsulitis; Corticosteroid; Distension; Frozen shoulder; PAINFUL STIFF SHOULDER; FROZEN SHOULDER; INTRAARTICULAR INJECTION; JOINT DISTENSION; NATURAL-HISTORY; PHYSIOTHERAPY; BLIND; INTERVENTIONS; MANIPULATION; INTENTION;
D O I
10.1186/s12891-016-1081-0
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Background: Optimal management for adhesive shoulder capsulitis (frozen shoulder) is currently unclear. We intended to explore whether treatment by intra-articular injections with corticosteroid and distension is more effective than treating with corticosteroids alone or treatment-as-usual in a primary care setting in Norway. Methods: In this prospective randomised intention to treat parallel study, 106 patients were block randomised to three groups; 36 (analysed 35) receiving steroid injection and Lidocaine (IS), 34 receiving steroid and additional saline as distension (ISD) and 36 had treatment-as-usual (TAU). Intervention groups received four injections within 8 weeks, assessed on 1st visit, at the 4th and 8th week. Outcomes were Shoulder Pain and Disability Index (SPADI), Numerical pain rating scale (NPRS) and passive range of motion (PROM). Postal assessment was repeated after 1 year for SPADI. Patients in the IS and ISD groups were "blinded" for intervention received and the assessor was "blinded" to group allocation. Results: At baseline there were no differences between groups in outcome measures. There were no statistical significant differences between the intervention groups in SPADI, NPRS and PROM at baseline, at short-term (4-and 8 weeks) or long-term (12 months). There were statistically significant differences (p < 0.01) in change scores at short-term for SPADI when comparing the IS and TAU groups (-20.8; CI-28.9 to -12.7), and the ISD and TAU groups (-21.7; CI-29.4 to -14.0), respectively for NPRS (-2.0; CI-2.8 to -1.1 and -2.2; CI-3.0 to -1.4), and for PROM, but not at long-term for SPADI (p > 0.05). Effect size (ES) at 8 weeks was large between both injection groups and TAU (ES 1.2). At 12 months ES was reduced to 0.3 and 0.4 respectively. Transitory side effects as flushing and after-pain were reported by 14 % in intervention groups. Conclusion: This intention to treat RCT in primary care indicates that four injections with corticosteroid with or without distension, given with increasing intervals during 8 weeks, were better than treatment-as-usual in treatment of adhesive shoulder capsulitis. However, in the long run no difference was found between any of the groups, indicating that natural healing takes place independent of treatment or not.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Regarding "A Multisite Injection Is More Effective Than a Single Glenohumeral Injection of Corticosteroid in the Treatment of Primary Frozen Shoulder: A Randomized Controlled Trial"
    Cho, Chul-Hyun
    Kim, Du Hwan
    Kim, Du-Han
    ARTHROSCOPY-THE JOURNAL OF ARTHROSCOPIC AND RELATED SURGERY, 2022, 38 (04): : 1032 - 1033
  • [42] Mental Health Specialist Video Consultations Versus Treatment-as-Usual for Patients With Depression or Anxiety Disorders in Primary Care: Randomized Controlled Feasibility Trial
    Toennies, Justus
    Hartmann, Mechthild
    Wensing, Michel
    Szecsenyi, Joachim
    Peters-Klimm, Frank
    Brinster, Regina
    Weber, Dorothea
    Vomhof, Markus
    Icks, Andrea
    Friederich, Hans-Christoph
    Haun, Markus W.
    JMIR MENTAL HEALTH, 2021, 8 (03):
  • [43] Treatment of anxiety disorders in primary care practice: a randomised controlled trial
    van Boeijen, CA
    van Oppen, P
    van Balkom, AJLM
    Visser, S
    Kempe, PT
    Blankenstein, N
    van Dyck, R
    BRITISH JOURNAL OF GENERAL PRACTICE, 2005, 55 (519): : 763 - 769
  • [44] Randomised trial of an inhaled β2 agonist, inhaled corticosteroid and their combination in the treatment of asthma
    Hancox, RJ
    Cowan, JO
    Flannery, EM
    Herbison, GP
    McLachlan, CR
    Wong, CS
    Taylor, DR
    THORAX, 1999, 54 (06) : 482 - 487
  • [45] Corticosteroid Injections Accelerate Pain Relief and Recovery of Function Compared With Oral NSAIDs in Patients With Adhesive Capsulitis: A Randomized Controlled Trial
    Ranalletta, Maximiliano
    Rossi, Luciano A.
    Bongiovanni, Santiago L.
    Tanoira, Ignacio
    Elizondo, Cristina M.
    Maigno, Gaston D.
    AMERICAN JOURNAL OF SPORTS MEDICINE, 2016, 44 (02): : 474 - 481
  • [46] CORTICOSTEROID TREATMENT OF ACTIVE ALCOHOLIC LIVER-DISEASE - CONTROLLED TRIAL
    MADDREY, WC
    BOITNOTT, JK
    WEBER, FL
    BEDINE, MS
    HARRINGTON, DP
    WHITE, RI
    MEZEY, E
    GASTROENTEROLOGY, 1975, 69 (03) : 843 - 843
  • [47] EARLY CORTICOSTEROID TREATMENT IN CHILDREN WITH IGA NEPHROPATHY: A RANDOMIZED AND CONTROLLED TRIAL
    Nuzzi, F.
    D'Armiento, M.
    Malgieri, G.
    Ferretti, A.
    Marzano, L.
    Pecoraro, C.
    PEDIATRIC NEPHROLOGY, 2009, 24 (09) : 1781 - 1781
  • [48] Corticosteroid injection for shoulder pain: single-blind randomized pilot trial in primary care
    Tim A Holt
    David Mant
    Andrew Carr
    Stephen Gwilym
    David Beard
    Christy Toms
    Ly-Mee Yu
    Jonathan Rees
    Trials, 14
  • [49] Economic evaluation of intensive home treatment in comparison to care as usual alongside a randomised controlled trial
    Barakat, Ansam
    Cornelis, Jurgen E.
    Dekker, Jack J. M.
    Lommerse, Nick M.
    Beekman, Aartjan T. F.
    Blankers, Matthijs
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2025, 26 (01): : 23 - 34
  • [50] Randomized trial of pulsed corticosteroid therapy for primary treatment of Kawasaki disease
    Newburger, Jane W.
    Sleeper, Lynn A.
    McCrindle, Brian W.
    Minich, L. LuAnn
    Gersony, Welton
    Vetter, Victoria L.
    Atz, Andrew M.
    Li, Jennifer S.
    Takahashi, Masato
    Baker, Annette L.
    Colan, Steven D.
    Mitchell, Paul D.
    Klein, Gloria L.
    Sundel, Robert P.
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (07): : 663 - 675